Daan Gene Co., Ltd. (SHE:002030)
China · Delayed Price · Currency is CNY 6.33
+0.02 (0.32%)
Jan 23, 2026, 12:40 PM CST
Daan Gene Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -563.95 | -925.17 | 104.66 | 5,412 | 3,618 | 2,449 | Upgrade |
Depreciation & Amortization | 345.06 | 345.06 | 357.14 | 298.44 | 192.02 | 72 | Upgrade |
Other Amortization | 18.58 | 18.58 | 10.82 | 34.78 | 20.45 | 10.26 | Upgrade |
Loss (Gain) From Sale of Assets | -9.1 | -9.1 | 3.04 | 1.15 | -0.11 | -0.14 | Upgrade |
Asset Writedown & Restructuring Costs | 29.37 | 29.37 | 80.89 | 329.79 | 15 | 18.72 | Upgrade |
Loss (Gain) From Sale of Investments | 429.58 | 429.58 | -409.44 | -345.15 | -135.35 | -436.39 | Upgrade |
Provision & Write-off of Bad Debts | 397.98 | 397.98 | 142.36 | 297.82 | 130.73 | 145.64 | Upgrade |
Other Operating Activities | -369.77 | 42.35 | 169.99 | 333.6 | 28.07 | 37.02 | Upgrade |
Change in Accounts Receivable | 745.69 | 745.69 | 1,768 | -2,659 | -953.23 | -934.41 | Upgrade |
Change in Inventory | 80.69 | 80.69 | -61.27 | -112.02 | -187.42 | -131.14 | Upgrade |
Change in Accounts Payable | -715.42 | -715.42 | -1,389 | 649.84 | 645.12 | 1,278 | Upgrade |
Operating Cash Flow | 249.43 | 300.33 | 780.11 | 4,155 | 3,305 | 2,515 | Upgrade |
Operating Cash Flow Growth | -60.30% | -61.50% | -81.22% | 25.73% | 31.42% | 2604.57% | Upgrade |
Capital Expenditures | -252.44 | -174.41 | -572.77 | -1,503 | -658.75 | -364.78 | Upgrade |
Sale of Property, Plant & Equipment | 0.26 | 0.11 | 0.45 | 0.01 | 0.15 | 0 | Upgrade |
Cash Acquisitions | - | - | - | - | -0.04 | - | Upgrade |
Divestitures | - | 0 | - | - | 0.02 | 0.47 | Upgrade |
Investment in Securities | -327.96 | -71.95 | 442.98 | -505.95 | -746.99 | -847.78 | Upgrade |
Other Investing Activities | 108.79 | 28.86 | 65.65 | 48.77 | 26.33 | 36.21 | Upgrade |
Investing Cash Flow | -471.35 | -217.39 | -63.69 | -1,960 | -1,379 | -1,176 | Upgrade |
Short-Term Debt Issued | - | 147.85 | 318.52 | 124.6 | 284.55 | 329.67 | Upgrade |
Long-Term Debt Issued | - | 46.8 | 35 | 50.03 | 45 | 13.58 | Upgrade |
Total Debt Issued | 185.58 | 194.65 | 353.52 | 174.64 | 329.55 | 343.25 | Upgrade |
Short-Term Debt Repaid | - | -357.67 | -125.46 | -284.34 | -398.75 | -917.39 | Upgrade |
Long-Term Debt Repaid | - | -15.06 | -82.7 | -104.33 | -52.08 | - | Upgrade |
Total Debt Repaid | -204.98 | -372.73 | -208.16 | -388.67 | -450.83 | -917.39 | Upgrade |
Net Debt Issued (Repaid) | -19.4 | -178.08 | 145.36 | -214.03 | -121.28 | -574.13 | Upgrade |
Common Dividends Paid | -3.39 | -27.88 | -2,469 | -1,570 | -496.31 | -58.99 | Upgrade |
Other Financing Activities | -31.44 | - | - | -10.96 | -8.96 | -52.14 | Upgrade |
Financing Cash Flow | -54.23 | -205.96 | -2,323 | -1,795 | -626.55 | -685.26 | Upgrade |
Foreign Exchange Rate Adjustments | 0.57 | 1.11 | 2.26 | 27.53 | -3.24 | -9.93 | Upgrade |
Net Cash Flow | -275.58 | -121.9 | -1,605 | 427.93 | 1,295 | 643.43 | Upgrade |
Free Cash Flow | -3.01 | 125.92 | 207.34 | 2,652 | 2,646 | 2,150 | Upgrade |
Free Cash Flow Growth | - | -39.27% | -92.18% | 0.24% | 23.08% | - | Upgrade |
Free Cash Flow Margin | -0.39% | 14.76% | 17.56% | 22.02% | 34.52% | 40.25% | Upgrade |
Free Cash Flow Per Share | -0.00 | 0.09 | 0.14 | 1.89 | 1.89 | 1.53 | Upgrade |
Cash Income Tax Paid | 51.31 | 50.76 | 253.76 | 1,504 | 754.19 | 364.63 | Upgrade |
Levered Free Cash Flow | 1,532 | 426.48 | 432.93 | 1,457 | 1,665 | 1,474 | Upgrade |
Unlevered Free Cash Flow | 1,536 | 432.57 | 439.21 | 1,466 | 1,671 | 1,488 | Upgrade |
Change in Working Capital | -37.15 | -37.15 | 320.01 | -2,206 | -555.75 | 215.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.